News Tag: research results
Trastuzumab with Chemoradiation and Surgery Does Not Improve Outcomes for Esophageal Cancer Patients, Trial Highlights Future Research Opportunities
Read More
NRG Oncology Trial Data Concludes Paclitaxel and Carboplatin Should be Considered the Standard of Care as First-line Treatment for Women with Uterine Carcinosarcoma
Read More
Bupropion Does Not Improve Sexual Desire for Female Cancer Survivors on NRG Oncology Clinical Study
Read More
NRG Oncology Non-Small Cell Lung Cancer Trial Completed Accrual to Phase 2, Undergoing Data Analysis to Determine Reopening for Phase 3
Read More
Hypofractionated Post-Operative Prostate Bed Radiotherapy Does Not Increase Patient-Reported Toxicity for Men with Prostate Cancer
Read More
Total Androgen Suppression with Dose-Escalated Radiotherapy Does Not Improve Overall Survival in Men with Intermediate-Risk Prostate Cancer: Results Highlight Need for Biomarker Studies
Read More
Breast Radiation following Lumpectomy Confirmed to Reduce Incidence of IBR for “Good Risk” DCIS
Read More
NRG Oncology’s Practice Changing Study on HA-WBRT plus Memantine Was Among Journal of Clinical Oncology’s Top 5 Downloads in 2020
Read More
Reduced-Dose Radiation with Cisplatin Improves Outcomes for HPV-associated Oropharyngeal Carcinoma Patients on NRG Oncology Study, Justifies Phase III Trial
Read More
NRG Oncology Trial Results Show Safety of Adaptive Radiotherapy in Non-Small Cell Lung Cancer Patients, Open Paths to Future Prospective Studies
Read More